Depressive Symptomatology in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: a Controlled Comparison
Document Type
Article
Publication Date
2015
Keywords
prostate cancer, oncology, androgen deprivation therapy, depression, quality of life
Digital Object Identifier (DOI)
https://doi.org/10.1002/pon.3608
Abstract
Objective: Prostate cancer patients who receive androgen deprivation therapy (ADT) often experience many physical and psychological side effects. ADT may be associated with increased risk for depression, but the relationship between ADT and depression is not fully understood. This study used a longitudinal design to assess depressive symptomatology in patients receiving ADT compared with two groups of matched controls.
Methods: Participants were men initiating ADT treatment (ADT+ group; n = 61) and their matched controls: prostate cancer patients treated with radical prostatectomy (ADT− group; n = 61), and no-cancer controls (CA− group; n = 61). Depressive symptomatology was assessed using the Center for Epidemiological Studies Depression Scale at ADT initiation and again 6 months later. Differences in depressive symptomatology and rates of clinically significant depressive symptomatology were analyzed between groups at each time point and within groups over time.
Results: Between baseline and follow-up, ADT+ participants demonstrated increased depressive symptomatology and increased rates of clinically significant depressive symptomatology (ps < 0.05). ADT+ participants also reported greater depressive symptomatology than both control groups at follow-up (ps < 0.001). Rates of clinically significant depressive symptomatology were higher in the ADT+ group than the ADT− and CA− groups at both time points (baseline: 28%, 5%, 12%; follow-up: 39%, 9%, 11%).
Conclusions: Findings support the hypothesis that ADT administration yields increases in depression and suggest that the mechanism behind ADT's association with depression should be explored and that prostate cancer patients treated with ADT should receive particular focus in depression screening and intervention.
Was this content written or created while at USF?
Yes
Citation / Publisher Attribution
Psycho-Oncology, v. 24, issue 4, p. 472-477
Scholar Commons Citation
Lee, Morgan; Jim, Heather S.; Fishman, Mayer; Zachariah, Babu; Heysek, Randy; Biagioli, Matthew; and Jacobsen, Paul B., "Depressive Symptomatology in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: a Controlled Comparison" (2015). Psychology Faculty Publications. 2472.
https://digitalcommons.usf.edu/psy_facpub/2472
